|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
1
|
|
pubmed:dateCreated |
2009-1-14
|
|
pubmed:abstractText |
Pathogen reduction methods have the potential to modify blood components, resulting in immunologic reactions or compromised blood components. This study evaluated the hypothesis that there is no immune response to riboflavin-and-ultraviolet [UV]-light-treated red blood cells (RBCs), as observed by serology and by survival of RBCs in circulation.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jan
|
|
pubmed:issn |
1537-2995
|
|
pubmed:author |
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
49
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
64-74
|
|
pubmed:meshHeading |
pubmed-meshheading:18954398-Animals,
pubmed-meshheading:18954398-Blood Transfusion, Autologous,
pubmed-meshheading:18954398-Cell Survival,
pubmed-meshheading:18954398-Disinfection,
pubmed-meshheading:18954398-Erythrocyte Transfusion,
pubmed-meshheading:18954398-Erythrocytes,
pubmed-meshheading:18954398-Immunoglobulin G,
pubmed-meshheading:18954398-Papio cynocephalus,
pubmed-meshheading:18954398-Photosensitizing Agents,
pubmed-meshheading:18954398-Riboflavin,
pubmed-meshheading:18954398-Ultraviolet Rays
|
|
pubmed:year |
2009
|
|
pubmed:articleTitle |
Evaluation of potential immune response and in vivo survival of riboflavin-ultraviolet light-treated red blood cells in baboons.
|
|
pubmed:affiliation |
Navigant Biotechnologies, Lakewood, Colorado 80227, USA. ray.goodrich@navigantbiotech.com
|
|
pubmed:publicationType |
Journal Article,
Research Support, U.S. Gov't, Non-P.H.S.
|
